Similar Items: Liver Injury in HIV-positive Patients on Antituberculosis and/or Antiretroviral Therapy – Assessing Causality
- Outcomes and cost-effectiveness of different models of delivery of antiretroviral therapy
- N-Acetylcysteine for non-paracetamol drug-induced liver injury: A systemic review
- The Plasma, Whole Blood and Intracellular Concentrations of Antiretroviral Agents in South African Children Receiving Combination Antiretroviral Therapy with and without Concomitant Antitubercular Treatment
- Antiretroviral therapy adherence and effectiveness in a private sector disease management programme in Southern Africa
- Determination of biomarkers for toxicity and antiretroviral adherence in hair in South African patients
- Clinical, pharmacokinetic, and genetic determinants of change in serum creatinine among Southern Africans on dolutegravir based antiretroviral therapy
Author: Cohen, Karen
- A randomised controlled trial of N-acetylcysteine in the management of anti-tuberculosis drug-induced liver injury
- Morbidity from antiretroviral metabolic effects in Africa: The Mama Study
- Liver Injury in HIV-positive Patients on Antituberculosis and/or Antiretroviral Therapy – Assessing Causality
- The burden of serious adverse drug reactions in South Africa
- Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis
- N-Acetylcysteine for non-paracetamol drug-induced liver injury: A systemic review